June 01, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
In an early study, a tissue-engineered heart muscle product was linked to improvements in heart wall thickness, left ventricular ejection fraction and quality of life in patients with heart failure with reduced EF. Biologic ventricular assist tissue (Repairon) is “the first tissue-engineered heart muscle product in clinical trials” and the phase 1 to 2 BioVAT-HF study, published in
June 01, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Dawn of Heart Muscle Patches to Address Lost Myocardium in Heart Failure

Heart patch engineered from stem cells revved up weakened hearts

Gene therapies to fix failing hearts gain steam after years in the doldrums

Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis

RNA therapy for genetic heart failure moves closer to patients after lab gains

Científicos desarrollan parche cardíaco con células madre que mejora la función del corazón en pacientes con insuficiencia grave

Un parche cardíaco podría mejorar la función del corazón en pacientes con insuficiencia cardíaca grave

Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life's VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology

Statt Transplantation: Herzpflaster verbessert Pumpleistung bei schwerer Herzschwäche - WELT

Statt Transplantation: Herzpflaster verbessert Pumpleistung bei schwerer Herzschwäche - WELT

Early report on modular BioVAT patches in advanced stage C or D disease

A stem cell-based heart patch improved pumping in a small trial for advanced heart failure. "Very good first step," researcher…

Treatments aim to bulk up failing hearts to restore their vigour – but can the field move on from past controversy?

Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development…

Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that…

Los resultados del ensayo clínico, publicado en The New England Journal of Medicine, indicaron mejoras significativas en 20…